In addition to ETS gene fusions and aberrant genetic alterations that activate the PI3K pathway (e.g., PTEN-loss), another frequent mutational event in prostate cancer is loss of regions within chromosome 8p21, to which the homeobox gene NKX3. 1 maps [12,13]. The gene discussed is PTEN; the disease is prostate carcinoma.